Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AUPH will decline by -6.36% over the next 2 Weeks and hit $14.25 by Monday, August 10, 2026. In that time frame, AUPH's share price is expected to range between $13.63 and $14.90.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 10, 2026 | 13.63 | 14.25 | 14.90 |
| Aug 7, 2026 | 13.96 | 14.58 | 15.24 |
| Aug 6, 2026 | 13.97 | 14.57 | 15.14 |
| Aug 5, 2026 | 14.09 | 14.71 | 15.29 |
| Aug 4, 2026 | 14.25 | 14.88 | 15.49 |
| Aug 3, 2026 | 14.12 | 14.69 | 15.27 |
| Jul 31, 2026 | 14.45 | 15.02 | 15.58 |
| Jul 30, 2026 | 14.47 | 15.01 | 15.60 |
| Jul 29, 2026 | 14.59 | 15.14 | 15.70 |
| Jul 28, 2026 | 14.76 | 15.32 | 15.88 |
AUPH shares fell -1.71% in Tuesday, July 28, 2026's trading session, dropping from a previous close of $15.22 to move at $14.96. The stock demonstrated notable intraday movement (see AUPH's key stats for a full breakdown), fluctuating between $14.90 and $15.38, a +3.26% trading range. While recent weeks have seen some volatility, AUPH has managed to secure a -6.38% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 1.06M shares changing hands, 264.2K more than the previous session. This amounted to $15.81M in total market activity.
Will AUPH Continue Its Downward Trend?
According to analyst ratings and projections for AUPH, Aurinia Pharmaceuticals Inc. shares are anticipated to decrease by -0.43%, potentially reaching $14.90 per share by August 10, 2026. Short-term technical indicators currently suggest a neutral sentiment for AUPH. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the AUPH stock forecast, now is not the best time to buy AUPH stock because its current trading price is +4.97% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on AUPH covering social and institutional perspectives.
AUPH Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AUPH's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.93% to 42.21%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 47.78%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.53%, maintains a neutral outlook for the long term. Insights into AUPH's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Aurinia Pharmaceuticals Short-Term Forecasts
AUPH Forecast For Next 5 Days
Our algorithm anticipates Aurinia Pharmaceuticals (AUPH) stock could hit $15.45 by Aug 04, 2026. This represents a +3.27% fall from today's price, following a -3.21% change over the past five days.
AUPH Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Aurinia Pharmaceuticals Inc. (AUPH) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $15.49, which would mean a +3.54% increase from the current price of $14.96. Projections for this period range from a high of $16.93 to a low of $14.18.
AUPH Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Aurinia Pharmaceuticals's price over the next three months point to a rise. AUPH stock is expected to peak at $17.34 on Oct 26, 2026 after potentially dipping to $13.64 on Aug 10, 2026. On average, AUPH is likely to trade around $15.60 in the coming 90 days.
Aurinia Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Aurinia Pharmaceuticals (AUPH) is expected to trade between $13.64 and $18.83 throughout 2026. This would result in an average price of $15.98, potentially offering investors a +6.82% return from current levels.
Aurinia Pharmaceuticals Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Aurinia Pharmaceuticals Inc. (AUPH) is positioned to show a strong performance in July 2026. The price is predicted to move between $13.94 and $16.19, settling at an average of $15.06. This could translate to a +0.67% gain.
August 2026
Based on current market signals, Aurinia Pharmaceuticals Inc. is projected to trend august 2026. We forecast a trading range from $13.64 to $16.52, with a likely average price of $15.10. Investors could expect a potential return of +0.94%.
September 2026
Our predictive algorithms indicate Aurinia Pharmaceuticals Inc. stock may see a shift in September 2026. The expected range spans $14.47–$17.17, with an average target of $15.77. This represents a positive outlook and a possible gain of +5.41%.
October 2026
Analyzing established trends, Aurinia Pharmaceuticals Inc. looks set to move in October 2026. Projections place the stock between $14.19 and $17.55, averaging around $16.08. This suggests a +7.49% gain from current levels.
November 2026
Market indicators suggest Aurinia Pharmaceuticals Inc. could experience notable changes during November 2026. Prices could fluctuate within $15.38 to $18.83, with a midpoint forecast of $16.71. The stock might deliver a +11.70% gain.
December 2026
Forecasting for December 2026, models estimate that Aurinia Pharmaceuticals Inc. may undergo key fluctuations. If trends hold, the stock might trade between $14.80 and $17.68, averaging $16.37. This signals a positive trajectory with potential returns around +9.43%.
January 2027
According to our latest forecast models, Aurinia Pharmaceuticals Inc. (AUPH) is positioned to show a strong performance in January 2027. The price is predicted to move between $14.57 and $17.64, settling at an average of $16.21. This could translate to a +8.36% gain.
February 2027
Based on current market signals, Aurinia Pharmaceuticals Inc. is projected to trend february 2027. We forecast a trading range from $15.53 to $18.28, with a likely average price of $16.82. Investors could expect a potential return of +12.43%.
March 2027
Our predictive algorithms indicate Aurinia Pharmaceuticals Inc. stock may see a shift in March 2027. The expected range spans $15.88–$18.65, with an average target of $17.17. This represents a positive outlook and a possible gain of +14.77%.
April 2027
Analyzing established trends, Aurinia Pharmaceuticals Inc. looks set to move in April 2027. Projections place the stock between $16.23 and $18.97, averaging around $17.66. This suggests a +18.05% gain from current levels.
May 2027
Market indicators suggest Aurinia Pharmaceuticals Inc. could experience notable changes during May 2027. Prices could fluctuate within $16.02 to $18.70, with a midpoint forecast of $17.41. The stock might deliver a +16.38% gain.
June 2027
Forecasting for June 2027, models estimate that Aurinia Pharmaceuticals Inc. may undergo key fluctuations. If trends hold, the stock might trade between $15.65 and $18.78, averaging $17.26. This signals a positive trajectory with potential returns around +15.37%.
July 2027
According to our latest forecast models, Aurinia Pharmaceuticals Inc. (AUPH) is positioned to show a strong performance in July 2027. The price is predicted to move between $16.55 and $19.27, settling at an average of $17.86. This could translate to a +19.39% gain.
AUPH's history of dividends and stock splits also plays a role in long-term investor confidence.